RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Pyrimidinol carboxylic acids were designed as inhibitors of HIV-1 RNase H function. These molecules can coordinate to two divalent metal ions in the RNase H active site. Inhibition of enzymatic activity was measured in a biochemical assay, but no antiviral effect was observed. Binding was demonstrated via a solid state structure of the isolated p15-Ec domain of HIV-1 RT showing inhibitor and two Mn(II) ions bound to the RNase H active site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nowotny, M., Gaidamakov, S. A., Crouch, R. J., & Yang, W. (2005) · Cell · doi:10.1016/j.cell.2005.04.024 · Cited by 620
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570
Hang, J. Q., Li, Y., Yang, Y., Cammack, N., Mirzadegan, T., & Klumpp, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.018 · Cited by 54
Cowan, J. A., Ohyama, T., Howard, K., Rausch, J. W., Cowan, S. M. L., & Le Grice, S. F. J. (2000) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750050009 · Cited by 51
Research works printed but not linked: 27
- Flexner C., 2007, Nature Rev. Drug Discovery, 6, 959, 10.1038/nrd2336 · DOI · Paper page
- Champoux J. J., 1993, Reverse Transcriptase, 103
- Tanese N., 1991, J. Virol., 65, 4387
- Klumpp K., 2006, Curr. Pharm. Des., 12, 1909, 10.2174/138161206776873653 · DOI · Paper page
- Loya S., 1990, Antimicrob. Agents Chemother., 34, 2009, 10.1128/AAC.34.10.2009 · DOI
- Klumpp K., 2003, Nucleic Acid Res., 31, 6852, 10.1093/nar/gkg881 · DOI · Paper page
- aWilliams, P. D.; Staas, D. D.; Venkatraman, S.; Booth, T. M.; Loughran, H. M.; Ruzek, R. D.; Wai, J. S.; Vacca, J. P.; Prasad, S.; Munshi, S. K.; Bahnck, C.; Dornadula, G.; Hrin, R. C.; Himmelberger, A. L.; Miller, M. D.; Hazuda, D. J.; Grobler, J. A.Inhibitors of the RNase H Activity of Reverse Transcriptase as an Approach to New HIV-1 Antiretroviral Agents.16th Conference on Retroviruses and Opportunistic Infections,Montreal,February 8−11, 2009.
- Fuji H., 2009, J. Med. Chem., 52, 1380, 10.1021/jm801071m · DOI
- Kirschberg T., 2007, Curr. Opin. Drug Discovery Dev., 10, 460
- Shaw-Reid C. A., 2005, Biochemistry, 44, 1595, 10.1021/bi0486740 · DOI · Paper page
- Hang J. Q., 2004, Biochem. Biophys. Res. Commun., 317, 321, 10.1016/j.bbrc.2004.03.061 · DOI
- Billamboz M., 2008, J. Med. Chem., 51, 7717, 10.1021/jm8007085 · DOI · Paper page
- Budihas S. R., 2005, Nucl. Acid Res., 33, 1249, 10.1093/nar/gki268 · DOI · Paper page
- Didierjean J., 2005, Antimicrob. Agents Chemother., 49, 4884, 10.1128/AAC.49.12.4884-4894.2005 · DOI · Paper page
- Piettre S. R., 1997, J. Am. Chem. Soc., 119, 3201, 10.1021/ja9634278 · DOI
- Parkes K. E. B., 2003, J. Med. Chem., 46, 1153, 10.1021/jm020334u · DOI · Paper page
- Zhuang L., 2003, J. Med. Chem., 46, 453, 10.1021/jm025553u · DOI · Paper page
- Tumey L. N., 2005, Bioorg. Med. Chem. Lett., 15, 277, 10.1016/j.bmcl.2004.10.086 · DOI
- Sang S., 2004, Bioorg. Med. Chem., 12, 459, 10.1016/j.bmc.2003.10.024 · DOI
- Summa V., 2004, J. Med. Chem., 47, 5336, 10.1021/jm0494669 · doi:10.1021/jm0494669
- Summa V., 2006, J. Med. Chem., 49, 6646, 10.1021/jm060854f · DOI
- Koch U., 2006, J. Med. Chem., 49, 1693, 10.1021/jm051064t · DOI
- Parniak M. A., 2003, Anal. Biochem., 332, 33, 10.1016/j.ab.2003.06.001 · DOI
- Beilhartz G. L., 2009, J. Mol. Biol., 388, 462, 10.1016/j.jmb.2009.03.025 · DOI · Paper page
- Yang W., 2008, Nature Struct. Mol. Biol., 15, 1228, 10.1038/nsmb.1502 · DOI · Paper page
- Bock C. W., 1999, J. Am. Chem. Soc., 121, 7360, 10.1021/ja9906960 · DOI · Paper page
- Pace P., 2007, J. Med. Chem., 50, 2225, 10.1021/jm070027u · DOI
Cited by
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Menéndez-Arias, L., Sebastián-Martín, A., & Álvarez, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.019 · Cited by 123
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
“One of the pyrimidinol carboxylic acids was successful crystallized with Mn and the isolated HIV RNase H domain [85].”
BackgroundResultInfluentialChung, S., Himmel, D. M., Jiang, J.-K., Wojtak, K., Bauman, J. D., Rausch, J. W., Wilson, J. A., Beutler, J. A., Thomas, C. J., Arnold, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000757 · Cited by 80
Metadata
- Authors
- Kirschberg, T. A., Balakrishnan, M., Squires, N. H., Barnes, T., Brendza, K. M., Chen, X., Eisenberg, E. J., Jin, W., Kutty, N., Leavitt, S., Liclican, A., Liu, Q., Liu, X., Mak, J., Perry, J. K., Wang, M., Watkins, W. J., & Lansdon, E. B.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-09-10
- Volume
- 52
- Issue
- 19
- Pages
- 5781-5784
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2035892275
- Cited by
- 95
- References
- 4
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.